Data / Form D filings / AndroJek, Inc.
AndroJek, Inc.: Form D filing
AndroJek, Inc., a biotechnology company in Kansas City, MO, filed a Form D with the SEC in 2011. The latest, on November 15, 2011, reports $400,000 sold of a $815,000 offering to 2 investors.
Find out what AndroJek, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 401 NE BARNES AVE., Kansas City, MO, 64118
- Phone
- (816) 679-3188
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2008
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1534960
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 15, 2011 | New notice | $815,000 | $400,000 | $415,000 | 2 | Oct 31, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| David B. Brown | Executive Officer, Director | |
| Michael C. Jackson | Executive Officer, Director |
Every Form D from the week of Nov 14, 2011 · All recent filings in Missouri · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what AndroJek, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.